テボゲン・バイオ・ホールディングスのニュース一覧

Tevogen Bio Expands IP Portfolio With Predictive AI Patent Filing To Advance T Cell Therapies And Accelerate AI Integration, Strengthening Position As An Industry Leader In Innovation And Accessibility

Benzinga12/19 21:34

Tevogen Bio to Attend the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire12/11 04:13

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Benzinga11/21 05:10

Wall Street Set to Open Higher Wednesday as Investors Await Nvidia's Earnings, Jobless Data

MT Newswires11/20 22:11

Tevogen Bio Says Its Internally Developed Intellectual Property And Product Assets, Valued Internally At $10B+ Using Discounted Cash Flow Models, Are Not Reflected On Balance Sheet

Benzinga11/20 05:59

Tevogen Bio Holdings Q3 EPS $(0.03) Same As Prior Year

Benzinga11/20 05:53

Tevogen Bio Holdings: Sufficient Available Cap to Fund Ops for at Least the Next 33 Mos >TVGN

Dow Jones11/20 05:53

Tevogen Bio Holdings 3Q Loss $4.3M >TVGN

Dow Jones11/20 05:52

10-Q：四半期報告書

SEC11/20 05:42

Tevogen Bio Delays Latest Quarterly Filing With SEC

WSJ11/16 06:26

Tevogen Bio Shares Are On The Rise Monday: What's Going On?

Benzinga11/12 04:33

Tevogen Bio Holdings Shares Are Trading Higher After the Company Announced It Is Near the Finalization of an Agreement With CD8 Technology for a Turn-key Facility Intended to Support Both Pre-clinical Research and GMP Manufacturing Capabilities. Also,...

Benzinga11/09 05:06

Press Release: Tevogen Bio CEO Dr. Ryan Saadi Expresses Gratitude for Prestigious ROI-NJ Recognition, Highlighting Company's Novel Business Model as Key to Sustainable Success Through Patient Affordability

Dow Jones11/06 05:43

Tevogen Bio Leverages Microsoft Partnership To Deliver Machine Learning Based Target Identification To Address HPV, Advancing TVGN 920

Benzinga11/05 22:29

12 Health Care Stocks Moving In Monday's Intraday Session

Benzinga11/05 00:40

EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In October 2024 — Where Do Tesla, Nvidia, Apple, DJT Stock Rank?

Benzinga11/05 00:05

Tevogen Bio Expands On Microsoft Partnership To Integrate Machine Learning And AI Into Preclinical Processes, Accelerating Drug Development And Reducing Costs; Says "Current Timeline For Drug Development Is 10-12 Years And Costs ~$1B-$3B. Approach Has...

Benzinga10/31 22:56

Tevogen Bio Reports That The Co Has Regained Nasdaq Listing Compliance

Benzinga10/30 03:37

Alpha Capital Appointed as Exclusive Financial Advisor to CD8 Technology to Secure Funding Up To $50 Million

GlobeNewswire10/30 02:38

Tevogen Bio Signs Letter Of Intent With CD8 Technology To Build Up To A $50M R&D And Manufacturing Facility; No Impact On Shareholder Equity

Benzinga10/30 00:45